(613)541-0192
`Res:
`Cell: (613)484-4112
`E-mail:
`Tim.smith@octaneco.com
`
`Timothy J.N. Smith Ph.D.
`
`
` 47 Copperfield Drive
` Kingston, Ontario
` K7M 1M3
`
`OVERVIEW
`
`Entrepreneurial Senior Executive with 25 years experience in commercialization of innovative medical
`products in international markets. Co-founder of four start up companies that all successfully progressed
`from new technology development through to global distribution agreements with leading multinationals.
`Leadership roles have generated wide experience and insight on, strategic planning, product
`commercialization, venture financing and team motivation.
`
`KEY SKILLS
`
`(cid:120) Team Builder
`Strategic thinker
`(cid:120)
`(cid:120) Leadership in company development
`Innovative and inventive
`(cid:120)
`(cid:120) Network savvy
`
`CORE COMPETENCIES
`
`(cid:120) Commercialization process from product concept through product sales
`(cid:120) Competitive strategies and factors influential in market positioning
`(cid:120) Milestone development connected with financial models and objectives
`(cid:120) Venture financing in both private equity and public market situations
`Partner identification agreement negotiations for joint programs and market access
`(cid:120)
`Intellectual property management and related patent tactics
`(cid:120)
`(cid:120) Regulatory approval pathways for medical devices in all major markets
`(cid:120) Technology transfer through in-licensing and out-licensing
`
`1 of 4
`
`MILLENIUM EXHIBIT 2008
`Baxter Healthcare Corp. et. al. v. Millenium Biologix, LLC
`IPR2013-00582,-00583,-00590,-00591
`
`

`
`MOST RECENT CAREER EXPERIENCE
`
`Octane Medical Group is a Canadian controlled, private corporation that is focused on the design,
`development and production of laboratory instrumentation and clinical systems that incorporate cell
`and tissue culture technologies. Octane Biotech Inc. is one of three companies in the Octane Medical
`Group. The other two companies are Octane Orthobiologics Inc., which has its focus in the area of
`biomaterials, and Octane OEM Inc., which offers contract clean room production for medical devices.
`
`2007-Present
`
`
`
`
`
`Co-founder and Chief Executive Officer
`(cid:120) Co-founder of cluster of Octane companies under Octane Medical Group
`(cid:120)
`Provide strategic direction on target markets and product commercialization
`Lead partnering activity in conjunction with senior management team
`(cid:120)
`(cid:120) Draft partnering term sheets and negotiate contracts in collaboration with Octane COO
`o Secured 3 corporate affiliations for international sales and marketing
`Identify financial goals and develop steps to reach targets
`(cid:120)
`(cid:120) Develop corporate communication message and company positioning
`Identify and implement strategic links with international academic and clinical centers
`(cid:120)
`o Alliances with 4 academic centers for research and development
`(cid:120) Generate business plans and channel financial planning
`
`Millenium Biologix Corporation was a small publicly traded biotech company focused on the
`development and commercialization of next generation bioactive medical devices (implants) and
`skeletal tissue regeneration products. Commercialized products include manufactured assays for
`culturing bone cells, artificial bone in varying formats and bone growth stimulators (peptides).The
`company is currently in end stage development of a bench-top automated bone cell replication
`instrument which when commercialized is targeted for use in knee cartilage surgeries. Millenium also
`developed/conducted experiments which research bone mass loss in astronauts on several space
`shuttle flights. Millenium’s technologies were acquired by Medtronic Corporation, Curative
`Biosciences and Octane Biotech.
`
`1992-2007
`
`(cid:120)
`
`Co-founder and Chief Operating Officer, in Kingston
`
`
`Co-founder of company and led fast development of innovative products
`(cid:120)
`Responsible for Company operations with emphasis on product commercialization
`(cid:120)
`o Brought four technology platforms through from concept to product launch
`(cid:120) Key part of partnering team focused on international marketing, distribution and sales
`o Secured 20+ agreements for market access from niche territories through multi-year global
`exclusive contracts
`Established comprehensive technical programs directed at the pursuit of the Company’s competitive
`vision for growth and profitability in the global orthopedics industry.
`(cid:120) Organized product development teams that could both deliver on contract R&D while simultaneously
`pursuing long term strategic programs.
`Prepared detailed financial models for use in establishing Company strategies and for incorporation into
`the Company’s Business Plan..
`Personally financed the start-up phase of the Company in conjunction with Sydney Pugh.
`Participated in follow-on financing rounds including the successful entry into public markets.
`Established excellent working relationships with important government agencies such as the National
`Research Council, Canadian Space Agency and Revenue Canada.
`Co-inventor of the Company’s patents on the Skelite technology.
`Responsibility for the care and maintenance of the Company’s international patent portfolio.
`Successfully implemented the adoption of ISO 9000 standards throughout the organization
`
`(cid:120)
`
`(cid:120)
`(cid:120)
`(cid:120)
`
`(cid:120)
`(cid:120)
`(cid:120)
`
`2 of 4
`
`

`
`Q-LIFE SYSTEMS INC. was formed to commercialize medical devices in the area of drug delivery
`systems. The company successfully established partnerships with American Home products and Xerox
`corporation
`
`1989-1992
`
`
`
`
`Intellectual Property Source and Vice President
`Responsible for product definition, product development, project budgeting, project staffing, project scheduling
`and manufacturing release.
`Led a development team comprised of life scientists, mechanical and electrical engineers, and
`(cid:120)
`software developers.
`(cid:120) Defined performance objectives and recruited staff for specific responsibilities.
`(cid:120) Managed the development of Q-Life’s lead products.
`Inventor in Q-Life’s technologies.
`(cid:120)
`(cid:120) Managed corporate patent portfolio.
`Prepared government contribution contracts for project cost recovery.
`(cid:120)
`Initiated and reported on feasibility studies.
`(cid:120)
`(cid:120) Operated within tight time and financial constraints.
`Responsible for obtaining market approvals from government regulatory agencies such as United
`(cid:120)
`States FDA.
`
` Member of Management Group for Q-Life Systems:
`Participated in the development of corporate strategy.
`(cid:120)
`Presented and supported product development strategies.
`(cid:120)
`Prepared executive milestone reports.
`(cid:120)
`Presented quarterly to Q-Life board of Directors.
`(cid:120)
`Participated in the preparation of Company Business Plans.
`(cid:120)
`(cid:120) Active in negotiation of partnering contracts.
`(cid:120) Organized and carried out tech-transfer from university collaborators.
`Performed detailed project management including critical path analysis.
`(cid:120)
`(cid:120) Accumulated detailed experience in a variety of technical fields, including biocompatible medical
`polymers, ceramic biomaterials, microprocessor systems, medical packaging and sterilization.
`
`EDUCATION AND CAREER DEVELOPMENT
`
`Ph.D., Biomechanics – Applied Science
`M.Sc., Biomechanics – Applied Science
`B.Sc., Mechanical Engineering
`
`
`Queen’s University
`Queen’s University
`Queen’s University
`
`
`
`
`
`1988
`1985
`1983
`
`Career Development
`(cid:120) Managing Innovation and Technology, School of Business
`(cid:120) Managing Marketing and Procurement, Engineering Design Unit
`(cid:120) Developing and Conducting Clinical Trials, Epidemiology
`
`PATENTS
`
`Over 200 patents pending in primary commercial territories:
`(cid:120) Advanced tissue engineering systems
`Synthetic bone grafts
`(cid:120)
`(cid:120) Composite biomaterials for drug delivery
`In vitro diagnostic and analytical devices
`(cid:120)
`Pharmaceutical delivery systems
`(cid:120)
`
`3 of 4
`
`

`
`ORGANIZATIONS
`
`(cid:120) Member of Board of Directors for Eastern Lake Ontario Regional Innovation Network
`(cid:120) Chairman of Eastern Ontario Biocluster Organization
`(cid:120) Committee Member of Parteq Innovations POP Grant Program
`(cid:120) Member HTX (Health Technology Exchange)
`
`
`
`
`
`
`
`
`
`4 of 4